Manmeet Singh Soni
CIK 1569769 · COO and CFO · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
RETA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
995 EAST ARQUES AVE
SUNNYVALE, CA 94085
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PLSE | Director | — | $50.20 | — | $0 | 12 | 2026-06-15 |
| SMMT | COO and CFO | 3,098,603 | $15.62 | $48.41M | $5.72M | 10 | 2026-06-04 |
| REATA PHARMACEUTICALS INC (RETA) Delisted | COO, CFO and President | 0 | $172.36 | $0 | -$22.66M | 17 | 2023-09-26 |
| ARENA PHARMACEUTICALS INC (ARNA) Delisted | Director | 5,902 | $99.99 | $590.1K | -$166.9K | 4 | 2020-06-18 |
| ALNY | Chief Financial Officer | 2 | $236.56 | $473 | $0 | 3 | 2019-03-01 |
| ARIAD PHARMACEUTICALS INC (ARIA) Delisted | EVP, CFO & Treasurer | 0 | $24.01 | $0 | $0 | 3 | 2017-02-16 |
Recent Filings · Page 4 of 7
68 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-04 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | +23,513 | $0 | EDGAR |
| 2022-05-23 | PLSE | Grant (A) | — | $0 | EDGAR |
| 2022-01-05 | SMMT | Grant (A) | — | $0 | EDGAR |
| 2022-01-05 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
| 2022-01-04 | REATA PHARMACEUTICALS INC (RETA) Delisted | Buy (P) | +16,000 | $419.6K | EDGAR |
| 2021-05-21 | PLSE | Grant (A) | — | $0 | EDGAR |
| 2021-02-23 | SMMT | Grant (A) | — | $0 | EDGAR |
| 2021-01-06 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-08-14 | REATA PHARMACEUTICALS INC (RETA) Delisted | Buy (P) | +3,000 | $300.6K | EDGAR |
| 2020-06-18 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Sell (S) | −304 | -$19.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.